
Robert Pyo MD
Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Director, Interventional Cardiology, Stony Brook Medicine; Director, Cardiac Catherterization Laboratories, Stony Brook University Hospital
Stony Brook University HospitalHealth Sciences Tower, Level 16 Rm 080Stony Brook, NY 11794
Fax+1 631-444-1054
Overview of Dr. Pyo
Dr. Robert Pyo is a cardiologist based in Stony Brook, NY, with subspecialties in interventional and peripheral endovascular interventional cardiology. He completed his medical education at the University of Illinois College of Medicine in 1996 and furthered his training with fellowships in cardiovascular disease and interventional cardiology at the Icahn School of Medicine at Mount Sinai. Dr. Pyo holds several notable leadership roles, including Director of the Cardiac Cath Lab at New York Presbyterian Brooklyn Methodist Hospital and Medical Director at Stony Brook University Hospital. His clinical expertise encompasses general cardiology, hypertension, coronary artery disease, valvular heart disease, and aortic stenosis. Dr. Pyo has contributed to cardiology literature with publications in well-regarded journals and is involved in clinical trials such as the SHIELD II Clinical Investigation.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Interventional Cardiology, 2006 - 2007
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2001 - 2006
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1999 - 2001
University of Illinois College of MedicineClass of 1996
Certifications & Licensure
NY State Medical License 2001 - 2027
LA State Medical License 2018 - 2019
NJ State Medical License 2013 - 2015
American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- SHIELD II Clinical Investigation Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 1 citationsPreclinical Efficacy of a Hemostatic Agent in Overcoming Dual Antiplatelet Therapy.Evgeni Efimenko, Hairu Zhao, Keith Moskowitz, Conrad Smith, Robert Pyo
JACC. Basic to Translational Science. 2025-09-01 - 3 citationsFuture Training Pathways in Percutaneous Coronary Interventions: Interventional Critical Care, Complex Coronary Interventions, and Interventional Heart Failure.Saraschandra Vallabhajosyula, Mirvat Alasnag, Konstantinos Dean Boudoulas, Laura J Davidson, Robert T Pyo
JACC. Advances. 2024-11-01 - 1 citationsTemporal trends in outcomes following inpatient transcatheter aortic valve replacement.Steven Imburgio, Sara Hazaveh, Lauren Klei, Anne Marie Arcidiacono, Shuvendu Sen
Cardiovascular Revascularization Medicine. 2024-10-01
Authored Content
- Does FFR-Guided Complete Revascularization in ACS Lead to Better Outcomes?September 2024
Press Mentions
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+March 31st, 2022
Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014September 21st, 2018
Heart Institute Uses Groundbreaking Technology to Treat High Blood PressureJanuary 26th, 2024
Professional Memberships
- Member
Other Languages
- Korean
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Healthfirst New YorkHIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare HMO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









